Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
President Trump's nominee for health secretary, Robert F. Kennedy Jr., was questioned harshly by both Democrats and ...
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
1d
Sysco allows restaurants to buy the bulk of its needs from a single source rather than dozens of producers, simplifying logistics and saving time. While the goods it sells are commodities, Sysco can ...
As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust ...
3don MSNOpinion
As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...
The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...
Independent drugstores are closing at an alarming rate, squeezed by the huge companies that reimburse pharmacies for costly ...
A bill that aims to increase pharmacy benefit managers’ transparency by requiring them to report data to the agency that ...
As PBM services have traditionally been dominated by large companies such as CVS Caremark, Express Scripts and OptumRx, health systems are starting to create alternatives. Here are four more things to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback